Detalhe da pesquisa
1.
Establishment of Safety Monitoring System for Vaccines Not Included in the National Immunization Program in Korea.
J Korean Med Sci
; 39(5): e45, 2024 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38317446
2.
Interim Estimates of 2023-2024 Seasonal Influenza Vaccine Effectiveness Among Adults in Korea.
J Korean Med Sci
; 39(15): e146, 2024 Apr 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38651226
3.
Effectiveness of Bivalent mRNA Booster Vaccine Against COVID-19 in Korea.
J Korean Med Sci
; 39(3): e15, 2024 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38258360
4.
Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database.
J Infect Dis
; 228(10): 1326-1335, 2023 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37549237
5.
Concurrent Subacute Thyroiditis and Graves' Disease After COVID-19: A Case Report.
J Korean Med Sci
; 38(18): e134, 2023 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37158771
6.
Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia.
BMC Infect Dis
; 22(1): 686, 2022 Aug 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35948963
7.
COVID-19 Vaccination in Korea: Past, Present, and the Way Forward.
J Korean Med Sci
; 37(47): e351, 2022 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36472087
8.
COVID-19 Vaccination Rates in Patients With Chronic Medical Conditions: A Nationwide Cross-Sectional Study.
J Korean Med Sci
; 37(45): e325, 2022 Nov 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36413798
9.
Immunogenicity and Reactogenicity of Ad26.COV2.S in Korean Adults: A Prospective Cohort Study.
J Korean Med Sci
; 37(27): e210, 2022 Jul 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35818701
10.
Clinical Characteristics and Risk Factors for Mortality in Critical Coronavirus Disease 2019 Patients 50 Years of Age or Younger During the Delta Wave: Comparison With Patients > 50 Years in Korea.
J Korean Med Sci
; 37(22): e175, 2022 Jun 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35668685
11.
COVID-19 Vaccination Strategies in the Endemic Period: Lessons from Influenza.
Vaccines (Basel)
; 12(5)2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38793765
12.
Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach.
Clin Microbiol Infect
; 30(5): 646-652, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38101473
13.
Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination.
Front Immunol
; 15: 1385135, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38756783
14.
Age-Stratified Seroprevalence of Respiratory Syncytial Virus: Analysis Using Prefusion F and G Protein Antibodies.
Vaccines (Basel)
; 12(5)2024 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38793764
15.
Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in Korea: interim analysis.
Front Immunol
; 15: 1382944, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38803497
16.
Effect of a Latent Tuberculosis Infection Programme for Healthcare Workers in a Country with an Intermediate Tuberculosis Burden.
J Hosp Infect
; 2023 Nov 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38040036
17.
Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosis.
Front Immunol
; 14: 1079277, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37051240
18.
Predictive and prognostic factors associated with unliquefied pyogenic liver abscesses.
J Microbiol Immunol Infect
; 56(1): 64-74, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35995667
19.
Effectiveness of Antiviral Therapy on Long COVID: A Systematic Review and Meta-Analysis.
J Clin Med
; 12(23)2023 Nov 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38068427
20.
Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate.
Hum Vaccin Immunother
; 19(3): 2266233, 2023 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37964587